Market Tracker

07/29 5:16am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

49.30
Delayed Data
As of Jul 28
 +1.74 / +3.66%
Today’s Change
19.67
Today|||52-Week Range
51.99
+55.28%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close47.56
Today’s open48.07
Day’s range-- - --
Volume1,161,199
Average volume (3 months)1,066,177
Market cap$4.8B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-44.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book15.37

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+3.54+3.02%
AKRXAkorn Inc+0.85+1.84%
NBIXNeurocrine Bioscienc...+2.58+5.23%
GRFSGrifols SA+0.04+0.13%
Data as of 07/28/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts